| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 614.40B | 645.22B | 610.52B | 555.84B | 492.69B | 441.80B |
| Gross Profit | 114.13B | 109.07B | 114.19B | 95.30B | 83.36B | 72.15B |
| EBITDA | 38.05B | 30.23B | 40.31B | 35.81B | 31.03B | 26.46B |
| Net Income | 21.29B | 11.14B | 22.10B | 19.00B | 15.58B | 7.90B |
Balance Sheet | ||||||
| Total Assets | 564.56B | 718.64B | 609.67B | 533.59B | 479.68B | 461.16B |
| Cash, Cash Equivalents and Short-Term Investments | 53.25B | 78.01B | 70.76B | 71.61B | 86.40B | 67.20B |
| Total Debt | 107.47B | 184.06B | 135.76B | 91.44B | 86.47B | 91.88B |
| Total Liabilities | 374.67B | 515.23B | 411.77B | 364.64B | 338.37B | 328.23B |
| Stockholders Equity | 181.24B | 196.81B | 189.37B | 162.66B | 139.62B | 131.30B |
Cash Flow | ||||||
| Free Cash Flow | -29.61B | -10.05B | -412.00M | -7.29B | 21.43B | 19.38B |
| Operating Cash Flow | -4.43B | 11.65B | 24.77B | 478.00M | 28.01B | 26.86B |
| Investing Cash Flow | -33.57B | -48.03B | -56.57B | -21.49B | -2.46B | 943.00M |
| Financing Cash Flow | 8.85B | 41.54B | 30.15B | -2.61B | -7.84B | -8.76B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥993.32B | 60.50 | 6.61% | 1.58% | -1.47% | -19.46% | |
75 Outperform | ¥240.03B | 18.20 | 9.02% | 3.11% | 9.57% | 40.16% | |
75 Outperform | ¥97.88B | 5.90 | ― | 3.20% | 6.98% | 164.25% | |
73 Outperform | ¥715.64B | 24.82 | ― | 1.43% | 8.81% | 17.58% | |
64 Neutral | ¥141.90B | 15.69 | 12.54% | 1.84% | 17.17% | 33.30% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥218.76B | 20.35 | ― | 2.41% | 5.68% | -49.64% |